PLoS ONE (Jan 2017)

Pulmonary vascular volume, impaired left ventricular filling and dyspnea: The MESA Lung Study.

  • Carrie P Aaron,
  • Eric A Hoffman,
  • Joao A C Lima,
  • Steven M Kawut,
  • Alain G Bertoni,
  • Jens Vogel-Claussen,
  • Mohammadali Habibi,
  • Katja Hueper,
  • David R Jacobs,
  • Ravi Kalhan,
  • Erin D Michos,
  • Wendy S Post,
  • Martin R Prince,
  • Benjamin M Smith,
  • Bharath Ambale-Venkatesh,
  • Chia-Ying Liu,
  • Filip Zemrak,
  • Karol E Watson,
  • Matthew Budoff,
  • David A Bluemke,
  • R Graham Barr

DOI
https://doi.org/10.1371/journal.pone.0176180
Journal volume & issue
Vol. 12, no. 4
p. e0176180

Abstract

Read online

BackgroundEvaluation of impaired left ventricular (LV) filling has focused on intrinsic causes of LV dysfunction; however, pulmonary vascular changes may contribute to reduced LV filling and dyspnea. We hypothesized that lower total pulmonary vascular volume (TPVV) on computed tomography (CT) would be associated with dyspnea and decrements in LV end-diastolic volume, particularly among ever-smokers.MethodsThe Multi-Ethnic Study of Atherosclerosis recruited adults without clinical cardiovascular disease in 2000-02. In 2010-12, TPVV was ascertained as the volume of arteries and veins in the lungs detectable on non-contrast chest CT (vessels ≥1 mm diameter). Cardiac measures were assessed by magnetic resonance imaging (MRI). Dyspnea was self-reported.ResultsOf 2303 participants, 53% had ever smoked cigarettes. Among ever-smokers, a lower TPVV was associated with a lower LV end-diastolic volume (6.9 mL per SD TPVV), stroke volume, and cardiac output and with dyspnea (all P-values ConclusionReductions in pulmonary vascular volume were associated with lower LV filling and dyspnea among ever-smokers, including those without lung disease, suggesting that smoking-related pulmonary vascular changes may contribute to symptoms and impair cardiac filling and function without evidence of impaired LV relaxation.